0001104659-21-090746.txt : 20210709
0001104659-21-090746.hdr.sgml : 20210709
20210709182856
ACCESSION NUMBER: 0001104659-21-090746
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210707
FILED AS OF DATE: 20210709
DATE AS OF CHANGE: 20210709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Mark K.
CENTRAL INDEX KEY: 0001786183
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39202
FILM NUMBER: 211083875
MAIL ADDRESS:
STREET 1: 227 7TH AVENUE NE
CITY: ST. PETERSBURG
STATE: FL
ZIP: 33701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annovis Bio, Inc.
CENTRAL INDEX KEY: 0001477845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262540421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
BUSINESS PHONE: 610-727-3913
MAIL ADDRESS:
STREET 1: 1055 WESTLAKES DRIVE, SUITE 300
CITY: BERWYN
STATE: PA
ZIP: 19312
FORMER COMPANY:
FORMER CONFORMED NAME: QR Pharma, Inc.
DATE OF NAME CHANGE: 20091202
4
1
tm2121908-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-07
0
0001477845
Annovis Bio, Inc.
ANVS
0001786183
White Mark K.
C/O ANNOVIS BIO, INC.
1055 WESTLAKES DRIVE, SUITE 300
BERWYN
PA
19312
1
0
0
0
Stock Option (right to buy)
102.85
2021-07-07
4
A
0
4000
0
A
2031-07-07
Common Stock
4000
4000
D
The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date.
/s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White
2021-07-09